A federal judge issued a preliminary injunction against a new government pilot set to significantly shift how certain ...

Court blocks US gov's 340B Rebate Model Pilot Program, citing failure to meet admin law reqs. Hospital groups argued for ...

A federal judge granted a temporary restraining order blocking the Department of Health and Human Services from launching its 340B Rebate Model Pilot Program, which was scheduled to begin Jan. 1, 2026 ...

The U.S. Department of Health and Human Services is appealing Monday's ruling that affects how much hospitals pay for drugs ...

As the January 1 implementation date approaches, here is a quick guide to the controversial new rebate model for the 340B Drug Pricing Program and the legal battle to stop it.

A federal judge in Maine has temproarily barred the Trump administration from implementing a new 340B drug rebate program for hospitals that was set to take effect on Jan. 1. The judge stated that the ...

As we look ahead to 2026, the operational demands on 340B programs are increasing across every dimension. Between the implementation of the 340B ...

Healthcare policy changes may increase uncompensated care, stressing hospitals and the 340B program, crucial for subsidizing low-income patient care. The 340B rebate model, starting in 2026, could ...

The past year has seen a great deal of controversy surrounding the 340B Drug Pricing Program, in which drug manufacturers make prescription drugs available to safety net healthcare providers at deeply ...

The 340B program is a prime example of public policy gone wrong. The original intent of the program was good, but based on current results, the program is flawed and is in desperate need of reform.

A late 2021 survey of hospitals participating in the 340B drug pricing program suggests pharma industry leaders’ recent restrictions on drug discounts are costing safety net hospitals hundreds of ...